
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC
Haoming Wu, Jikun Feng, Wenjing Zhong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Haoming Wu, Jikun Feng, Wenjing Zhong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Showing 10 citing articles:
Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
Pengfei Huang, Xinyue Zhou, Minying Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Pengfei Huang, Xinyue Zhou, Minying Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN/Hippo/YAP axis
Xuedong Wang, Q Jian, Ziyun Zhang, et al.
Translational Oncology (2024) Vol. 49, pp. 102076-102076
Open Access | Times Cited: 4
Xuedong Wang, Q Jian, Ziyun Zhang, et al.
Translational Oncology (2024) Vol. 49, pp. 102076-102076
Open Access | Times Cited: 4
AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization
Zhenkun Liu, Siyuan Hu, Xinlei Zhao, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009877-e009877
Open Access | Times Cited: 3
Zhenkun Liu, Siyuan Hu, Xinlei Zhao, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009877-e009877
Open Access | Times Cited: 3
Prognostic model based on M2 macrophage-related signatures for predicting outcomes, enhancing risk stratification, and providing therapeutic insights in diffuse large B-cell lymphoma
Baoping Guo, Ying Duan, Hong Cen
Heliyon (2024) Vol. 10, Iss. 24, pp. e41007-e41007
Closed Access | Times Cited: 2
Baoping Guo, Ying Duan, Hong Cen
Heliyon (2024) Vol. 10, Iss. 24, pp. e41007-e41007
Closed Access | Times Cited: 2
MS4A superfamily molecules in tumors, Alzheimer’s and autoimmune diseases
Xuejiao Luo, Bin Luo, Fei Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Xuejiao Luo, Bin Luo, Fei Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Albumin-based nanosystem for dual-modality imaging-guided chem-phototherapy against immune-cold triple-negative breast cancer
Peng Chen, Xiaodie Zeng, Jiali Cai, et al.
Regenerative Biomaterials (2023) Vol. 10
Open Access | Times Cited: 6
Peng Chen, Xiaodie Zeng, Jiali Cai, et al.
Regenerative Biomaterials (2023) Vol. 10
Open Access | Times Cited: 6
ASB1 inhibits prostate cancer progression by destabilizing CHCHD3 via K48-linked ubiquitination
Chunchun Zhao, Zhen Xu, Hongliang Que, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3404-3418
Open Access | Times Cited: 1
Chunchun Zhao, Zhen Xu, Hongliang Que, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3404-3418
Open Access | Times Cited: 1
A novel iTreg ‐related signature for prognostic prediction in lung adenocarcinoma
Jian Zhang, Yan Li, Yue Yang, et al.
Cancer Science (2023) Vol. 115, Iss. 1, pp. 109-124
Open Access | Times Cited: 3
Jian Zhang, Yan Li, Yue Yang, et al.
Cancer Science (2023) Vol. 115, Iss. 1, pp. 109-124
Open Access | Times Cited: 3
Integrated analysis reveals prognostic correlation and immune characteristics of a tumor-associated macrophage-based risk signature in triple-negative breast cancer
Shichen Miao, Chengyu Bian, Jun Fang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5214-5232
Open Access
Shichen Miao, Chengyu Bian, Jun Fang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5214-5232
Open Access
Prognostic correlation and immune characteristics of a TAM cluster- related 8-gene risk signature in triple-negative breast cancer
Shichen Miao, Chengyu Bian, Shanshan Wang, et al.
Research Square (Research Square) (2023)
Open Access
Shichen Miao, Chengyu Bian, Shanshan Wang, et al.
Research Square (Research Square) (2023)
Open Access